Analysed MEDICINOVA INC (MNOV:NASDAQ) News Sources
New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation
27-04-2026
yahoo.com
MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
26-05-2026
yahoo.com
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
08-06-2026
yahoo.com
Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight
08-06-2026
yahoo.com
What is the current price of MEDICINOVA INC (MNOV:NASDAQ)?
The current price of MEDICINOVA INC (MNOV:NASDAQ) is $1.35.
MEDICINOVA INC (MNOV:NASDAQ) absolute price change since previous trading day?
The absolute price change of MEDICINOVA INC (MNOV:NASDAQ) since the previous trading day is $-0.07.
MEDICINOVA INC (MNOV:NASDAQ) percentage price change since previous trading day?
The percentage price change of MEDICINOVA INC (MNOV:NASDAQ) since the previous trading day is -4.9296%.
What is the most recent average sentiment score for MEDICINOVA INC (MNOV:NASDAQ)?
The most recent average sentiment score for MEDICINOVA INC (MNOV:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for MEDICINOVA INC (MNOV:NASDAQ)?
The most recent sentiment for MEDICINOVA INC (MNOV:NASDAQ) is .
SEC-8K** Filing Available For MEDICINOVA INC (MNOV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.